Richen Europe S.r.l.

Richen Europe S.r.l. is a Pharmaceutical Company founded in 2014 as a subsidiary of the RICHEN MEDICAL SCIENCE GROUP and reference for the European market. We manufacture our own Medical Diagnostic and Medical Instruments focused on Gastroenterology field. The company that has developed 13C-UBT (13C urea breath test) diagnosis system in 2004, featuring the following scientific theories of modern medic treatment: non-invasive, analgesia and micro-scale. This system is characterised by safe, highly accurate, pollution-free, non-toxicant, and easily use. Since high sensitivity and specificity has become the golden standard of HP diagnosis, the infrared spectrometer thereupon has prompted the high distinguishability, completely in accordance with international concepts. Richen Medical Science Group now occupies nearly 70% of market shares in domestic China, which makes it become one of the most competitive enterprises related to 13C-UBT in China, even to the world.